lvv-hemorphin-7 has been researched along with candesartan in 1 studies
Studies (lvv-hemorphin-7) | Trials (lvv-hemorphin-7) | Recent Studies (post-2010) (lvv-hemorphin-7) | Studies (candesartan) | Trials (candesartan) | Recent Studies (post-2010) (candesartan) |
---|---|---|---|---|---|
59 | 0 | 14 | 1,929 | 412 | 589 |
Protein | Taxonomy | lvv-hemorphin-7 (IC50) | candesartan (IC50) |
---|---|---|---|
Epidermal growth factor receptor | Homo sapiens (human) | 3.2769 | |
Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 5.9472 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 3.0652 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 9 | |
Adenosine receptor A3 | Homo sapiens (human) | 1.2199 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 3 | |
Beta-3 adrenergic receptor | Homo sapiens (human) | 4.3 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 1.2199 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 3.843 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 3.0652 | |
Thromboxane-A synthase | Homo sapiens (human) | 3.0594 | |
Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0405 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 1.2199 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ebinger, G; FourniƩ-Zaluski, MC; Michotte, Y; Sarre, S; Stragier, B; Vanderheyden, P; Vauquelin, G | 1 |
1 other study(ies) available for lvv-hemorphin-7 and candesartan
Article | Year |
---|---|
Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Hemoglobins; Imidazoles; Male; Methionine; Microdialysis; Naltrexone; Narcotic Antagonists; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Sulfonic Acids; Tetrazoles; Time Factors | 2004 |